167 results
Page 3 of 9
8-K
EX-10.1
4h41f7kvq6d8rzl3bs
13 Aug 21
Entry into a Material Definitive Agreement
4:05pm
10-KT
EX-10.31
r41ya
31 Mar 21
Annual report (with FYE transition)
4:33pm
8-K
EX-10.4
a0noqv68y zel0j
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.1
7qzppto71r v8
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.2
esyvdrd0r2yk
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.5
qej 5xk2thcv9j
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.3
75mtviytyznc
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
8-K
EX-10.1
x547o9 jkhsb9hk
9 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.3
lj1g vt9i9z
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.2
mljd8cooh1 qy
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.1
nqysg
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.4
f6zx74hx 3mgusg
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.3
cjtddrkwk hhp4i
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm